OptiMedica

What OptiMedica does

OptiMedica Corporation is a medical device company founded in 2004 and headquartered in Santa Clara, California. Per its company description, OptiMedica develops performance-driven technologies for ophthalmologists aimed at transforming existing standards of care. The company's core product is the Catalys Precision Laser System, a laser-assisted cataract surgery platform that performs 3D eye scanning and image-guided surgical steps, and which is now featured within Johnson & Johnson Vision's cataract surgery portfolio alongside complementary offerings in IOLs, phacoemulsification systems, and digital surgical-planning tools.

Underlying technology centers on precision laser guidance combined with image-based treatment planning, allowing surgeons to execute key steps of the cataract procedure with image-derived accuracy rather than freehand technique. The platform integrates with downstream surgical workflows via J&J Vision's professional channel, which references a community of more than 40,000 eye health professionals. The Catalys system is positioned within an ecosystem that includes IOL and implant products, phacoemulsification systems, and digital calculators (TECNIS Toric, LRI, Vision Simulator) for surgical planning.

The business model is a capital-equipment medical device sale with associated service and consumables revenue, distributed through Johnson & Johnson Vision's professional sales force. OptiMedica historically operated as a venture-backed private company, raising approximately $85 million across five funding rounds between 2005 and 2012 from Kleiner Perkins, Alloy Ventures, DAG Ventures, BlackRock, and Bio*One Capital, and has since been integrated into the J&J Vision franchise (via Abbott Medical Optics). The firmographics file's claim of 10,000+ employees is a data contamination artifact from J&J Vision's broader workforce and does not reflect OptiMedica's standalone headcount.

Name

OptiMedica

Website

https://optimedica.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

OptiMedica Corporation, founded in 2004 in Santa Clara, California, developed performance-driven ophthalmic technologies, most notably the Catalys Precision Laser System for laser-assisted cataract surgery, now part of Johnson & Johnson Vision's cataract surgery portfolio.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Lasers (Cataract Surgery Devices)

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

akta.pro secondary industry

Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)

Keywords

• Cataract surgery lasers
• Ophthalmic surgical devices
• Precision laser systems
• Femtosecond cataract platform
• Ophthalmologist medical equipment

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Core offering

OptiMedica develops and commercializes performance-driven laser technology for ophthalmologists, with its flagship Catalys Precision Laser System enabling image-guided, laser-assisted cataract surgery. The platform integrates 3D spectral-domain OCT imaging with a femtosecond laser to deliver precise capsulotomies, lens fragmentation, and corneal incisions intended to elevate surgical experience and patient outcomes. The company sells these surgical laser platforms to ophthalmic practices, ambulatory surgical centers, and hospitals, and the technology is now distributed alongside Johnson & Johnson Vision's broader cataract surgery suite.

Differentiator

Problem solved

Functional benefit

Products and services

• Catalys Precision Laser System An image-guided, laser-assisted cataract surgery platform for ophthalmologists and surgical centers; integrates 3D spectral-domain OCT imaging with a femtosecond laser to deliver precise capsulotomies, lens fragmentation, and corneal incisions intended to elevate the surgical experience and patient outcomes.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights4 records

Direct peers

• Alcon: Alcon is the dominant ophthalmic surgical manufacturer and markets the LenSx femtosecond laser system for laser cataract surgery alongside its ORA System and IOL portfolio — directly comparable to OptiMedica's Catalys/phaco/IOL stack for the same ophthalmologist customer base.
• Carl Zeiss Meditec: Carl Zeiss Meditec supplies surgical ophthalmic equipment, IOLs (CT LUCIA, CT SPHERIS), and intraoperative diagnostics used by cataract surgeons. Comparable to OptiMedica in that it bundles imaging, laser/cataract surgical equipment, and premium IOLs targeting the same surgical practice workflow.
• Ziemer Ophthalmic Systems: Ziemer manufactures femtosecond surgical lasers (LDV) used in cataract and corneal surgery, competing head-to-head with OptiMedica's Catalys for the same ophthalmic surgeon adoption decision.
• NIDEK: NIDEK manufactures ophthalmic surgical devices including phacoemulsification systems, a competitor in the cataract surgical suite where OptiMedica's phaco and laser platforms compete.
• LENSAR: LENSAR is a focused pure-play in femtosecond laser cataract surgery (ALY/ALLY system), making it a direct technology competitor to OptiMedica's Catalys platform for ASC and hospital cataract programs.
• STAAR Surgical: STAAR Surgical is an ophthalmic implants company (ICL, IOLs) that competes in the premium vision correction and cataract IOL space adjacent to OptiMedica's implant and laser-based refractive/cataract solutions.

Broad incumbents

• Bausch + Lomb (Bausch Health): Bausch + Lomb is a broad-line incumbent in cataract surgery (IOLs, viscoelastics, surgical instruments) and a broader vision care portfolio. Overlaps with OptiMedica's cataract surgery franchise but competes across many more categories including contact lenses and pharmaceuticals.
• Johnson & Johnson Vision: J&J Vision is the acquirer/parent commercial channel for OptiMedica's cataract assets (Catalys, TECNIS IOLs, phaco) and serves the same ophthalmic surgical customers; it is a broad incumbent that now owns and distributes the OptiMedica product line.

Emerging players

• Heidelberg Engineering: Heidelberg Engineering provides diagnostic imaging used in ophthalmic practices (OCT, confocal imaging); partial overlap with OptiMedica's imaging-enabled Catalys workflow within ophthalmologist clinical and surgical decision-making.

Others

• Abbott Medical Optics: Abbott Medical Optics is the predecessor entity that acquired OptiMedica's technology platform and whose ophthalmic surgical business became part of J&J Vision. Relevant as the historical acquirer and as an enabling channel for OptiMedica's products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/optimedica
• Facebookfacebook.com/abbottcareers
• LinkedInlinkedin.com/company/optimedica

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OptiMedica